American Vietnamese Biotech

American Vietnamese Biotech Net Margin

The Net Profit Margin of American Vietnamese Biotech (AMV.VN) as of Oct 17, 2026 is -3.61 %. In the previous year, Net Profit Margin was 5.44 % — a change of -166.34% (lower).

Net Margin

-3.61 %

YoY

-166.34%

Last updated:

Net Profit Margin of American Vietnamese Biotech is 2024 -3.61 % . Net Profit Margin of American Vietnamese Biotech was 2023 5.44 % . It decreases by -166.34% lower compared to the previous year.

For American Vietnamese Biotech, the net margin of -3.6% is down versus 52.2% a few years ago.

The American Vietnamese Biotech Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2017
53.41 VND
Jan 1, 2018
47.72 VND
Jan 1, 2019
45.11 VND
Jan 1, 2020
52.24 VND
Jan 1, 2021
35.70 VND
Jan 1, 2022
19.18 VND
Jan 1, 2023
5.44 VND
Jan 1, 2024
-3.61 VND
The American Vietnamese Biotech Net Margin history
YEARNet MarginYoY
-3.61 %-166.34%
5.44 %-71.66%
19.18 %-46.26%
35.70 %-31.67%
52.24 %+15.81%
45.11 %-5.47%
47.72 %-10.66%
53.41 %+647.18%
7.15 %-188.02%
-8.12 %-96.32%
-220.58 %-1.18 M%
0.02 %-133.87%
-0.06 %-80.53%
-0.28 %-266.24%
0.17 %+21.48%
0.14 %-23.48%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

American Vietnamese Biotech Stock analysis

What does American Vietnamese Biotech do? American Vietnamese Biotech Inc, headquartered in Ho Chi Minh City, Vietnam, operates in the Health Care sector. The company manufactures and distributes high-tech medical diagnostics devices, equipment, medicines, vaccines, biological products, rapid diagnostic tests, and ELISA kits. It also trades medical equipment and tools, produces cosmetic, soap, detergent, and cleaning products, and engages in real estate trading, financial investments, and plastic product manufacturing. Listed on December 20, 2009, the company had one wholly owned subsidiary as of 2012. American Vietnamese Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about American Vietnamese Biotech stock

Net Profit Margin of American Vietnamese Biotech is -3.61 % in 2024.

Net Profit Margin of American Vietnamese Biotech changed from 5.44 % to -3.61 %, representing a -166.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin American Vietnamese Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's American Vietnamese Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — American Vietnamese Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — American Vietnamese Biotech